rs62637702

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004562.3(PRKN):​c.*94A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0261 in 684,804 control chromosomes in the GnomAD database, including 228 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 50 hom., cov: 32)
Exomes 𝑓: 0.027 ( 178 hom. )

Consequence

PRKN
NM_004562.3 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.101

Publications

3 publications found
Variant links:
Genes affected
PRKN (HGNC:8607): (parkin RBR E3 ubiquitin protein ligase) The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. [provided by RefSeq, Jul 2008]
PRKN Gene-Disease associations (from GenCC):
  • autosomal recessive juvenile Parkinson disease 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-161350005-T-C is Benign according to our data. Variant chr6-161350005-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 903814.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0246 (3733/151710) while in subpopulation AFR AF = 0.0359 (1486/41430). AF 95% confidence interval is 0.0344. There are 50 homozygotes in GnomAd4. There are 1879 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKNNM_004562.3 linkc.*94A>G 3_prime_UTR_variant Exon 12 of 12 ENST00000366898.6 NP_004553.2 O60260-1X5DR79

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKNENST00000366898.6 linkc.*94A>G 3_prime_UTR_variant Exon 12 of 12 1 NM_004562.3 ENSP00000355865.1 O60260-1

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3726
AN:
151606
Hom.:
50
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0358
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.0271
Gnomad EAS
AF:
0.000970
Gnomad SAS
AF:
0.0356
Gnomad FIN
AF:
0.0419
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0180
Gnomad OTH
AF:
0.0261
GnomAD4 exome
AF:
0.0265
AC:
14136
AN:
533094
Hom.:
178
Cov.:
8
AF XY:
0.0270
AC XY:
7638
AN XY:
282608
show subpopulations
African (AFR)
AF:
0.0512
AC:
728
AN:
14206
American (AMR)
AF:
0.0192
AC:
532
AN:
27756
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
588
AN:
16588
East Asian (EAS)
AF:
0.000851
AC:
22
AN:
25856
South Asian (SAS)
AF:
0.0424
AC:
2322
AN:
54756
European-Finnish (FIN)
AF:
0.0411
AC:
1290
AN:
31354
Middle Eastern (MID)
AF:
0.0416
AC:
115
AN:
2764
European-Non Finnish (NFE)
AF:
0.0230
AC:
7661
AN:
332680
Other (OTH)
AF:
0.0324
AC:
878
AN:
27134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
653
1305
1958
2610
3263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0246
AC:
3733
AN:
151710
Hom.:
50
Cov.:
32
AF XY:
0.0253
AC XY:
1879
AN XY:
74148
show subpopulations
African (AFR)
AF:
0.0359
AC:
1486
AN:
41430
American (AMR)
AF:
0.0166
AC:
252
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.0271
AC:
94
AN:
3466
East Asian (EAS)
AF:
0.000972
AC:
5
AN:
5142
South Asian (SAS)
AF:
0.0355
AC:
170
AN:
4792
European-Finnish (FIN)
AF:
0.0419
AC:
440
AN:
10490
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0180
AC:
1223
AN:
67878
Other (OTH)
AF:
0.0253
AC:
53
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
180
360
540
720
900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0251
Hom.:
17
Bravo
AF:
0.0242

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 20, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23275044) -

Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive juvenile Parkinson disease 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.5
DANN
Benign
0.37
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62637702; hg19: chr6-161771037; COSMIC: COSV58234052; COSMIC: COSV58234052; API